Patexia Logo
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
  • All Products
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
  • All Services
IP Community
  • IP Community
  • IP Webinars
  • In the News
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Login
JoinBook a Meeting
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Resources
  • IP Community
  • IP Webinars
  • In the News
  • Help Center
Contact
  • (310) 909-7611
  • 100 Wilshire Blvd. Suite 700
    Santa Monica, CA 90401 USA
  • info@patexia.com
  • Send a message
Follow Us
Terms and Conditions|Privacy Policy
© 2010-2023 Patexia Inc. All Rights Reserved.
Back to All Articles
Browse articles with tag: Hatch-waxman
You must be logged in to create a new article
All Articles
Susanne Melo
Aug 28, 2024
•
ANDA Litigation
Introducing the 2024 ANDA Litigation Intelligence Report: Insights into the Competitive Pharmaceutical Landscape
As the pharmaceutical industry continues to face an ever-changing legal environment, staying informed about trends in ANDA litigation has never... Read More
Pedram Sameni
Aug 14, 2024
•
ANDA Litigation
Patexia Insights 215: Benefits and Challenges of Multidistrict Litigations in Hatch-Waxman cases
When several ANDA filers seek approval for the same drug, a branded pharmaceutical company may struggle to bring Hatch-Waxman Act... Read More
Pedram Sameni
Dec 21, 2023
•
Featured
ANDA Litigation
Patexia Insight 196: Top ANDA Firms of 2023
In late August of this year, our ANDA Intelligence 2023 Report was released, a comprehensive study, covering the Hatch-Waxman litigation... Read More
Mikele Bicolli
Dec 12, 2023
•
Featured
ANDA Litigation
Patent Prosecution
Exploring the Use of 'March-In' Rights: Biden Administration's Consideration on Drug Patents and Pricing
  The Biden administration is exploring the use of "march-in" rights established in the 1980 Bayh-Dole Act, which has never... Read More
Pedram Sameni
Aug 30, 2023
•
Featured
ANDA Litigation
Patexia Insight 185: From Flux to Surge: Is ANDA Litigation Rising?
We are proud to announce that tomorrow marks the release of the fourth edition of our ANDA Litigation Intelligence Report.... Read More
Mikele Bicolli
Aug 23, 2023
•
Featured
ANDA Litigation
ANDA Litigation Resolutions: A Closer Look at Settlements and Their Consequences
    In the intricate world of pharmaceuticals, where innovation meets regulation, ANDA litigation stands as a pivotal battleground. Abbreviated... Read More
  • <
  • 1
  • 2
  • ...
  • 7
  • >